Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liraglutide for overweight and obesity management in people with schizophrenia
ISRCTN61129760Phase 3Completed
- Sponsor
- Southern Health NHS Foundation Trust
- Start
- Jul 2018
- Modality
- Peptides
01
Overview
Phase 3, randomised trial in obesity, Overweight, schizophrenia and 2 more comparing Liraglutide with Placebo (2 arms). Primary endpoints: Time to recruitment target, Number screened to reach recruitment target and 3 more. Started Jul 2018; status: completed.
02
Drugs
03
Conditions
obesityOverweightschizophreniaschizoaffective disorderpsychosis
Beyond the preview
Go deeper on ISRCTN61129760.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN61129760.